SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 762.19 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 181.25 |
| Book Value / Share | 1.08 |
| Price / Book | n/a |
| NCAV ($M) | -19.77 |
| NCAV / Share | -0.12 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.02 |
| Return on Equity (ROE) | -0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.14 |
| Current Ratio | 2.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 299.01 |
| Assets | 500.03 |
| Liabilities | 318.78 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 169.58 |
| Operating Income | -77.06 |
| Net Income | -12.25 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -67.22 |
| Cash from Investing | 76.92 |
| Cash from Financing | 30.68 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| IMUC – EOM Pharmaceuticals Holdings, Inc. | INBP – Integrated BioPharma, Inc. |
| INFIQ – Infinity Pharmaceuticals, Inc. | INTI – Inhibitor Therapeutics, Inc. |
| IOFNF – Iofina plc |
Financial data and stock pages provided by
Fintel.io